Analysis of Participation of Clinical Pharmacists in Examination of General Medical Orders in Department of Oncology

OBJECTIVE To investigate the medical orders in department of oncology and to ensure the reasonable and safe use of clinical medicine. METHODS The clinical pharmacists condueted a full medical examination of the oncology department. and the court conditions in 2017 was summarized and analyzed. RESULTS In the whole year of 2017, the clinical pharmacists reviewed 16 754 medical orders, among which 201 were not reasonable, and the total irrational rate was 1.20%. In the first quarter, the second quarter, the third quarter and the fourth quarter, the irrational rate was 1.62%, 1.42%, 0.95% and 0.77% respectively. The irrationality manifested as irrational pretreatment of chemotherapy drug, irrational interval of drug administration, irrational dose or type of solvents, irrational drug administration time, inconformity between drugs and clinical diagnosis, improper drug dosage, irrational drug delivery route, repeated medication and irrational drug choice. The proportion of the total number of irrational orders were 17.4%, 15.9%, 15.4%, 13.4%, 11.9%, 10.9%, 9.0%, 4.0% and 2.0% respectively. CONCLUSION In 2017, the irrational rate of medical orders in department of oncology is gradually decreasing according to the quarter, and it may proves that the review of general medical orders and timely intervention of clinical pharmacists are effective for rational drug use.